226 related articles for article (PubMed ID: 16698084)
1. Selective hypoxia-cytotoxins based on vanadyl complexes with 3-aminoquinoxaline-2-carbonitrile-N1,N4-dioxide derivatives.
Vieites M; Noblía P; Torre MH; Cerecetto H; Laura Lavaggi M; Costa-Filho AJ; Azqueta A; de Cerain AL; Monge A; Parajón-Costa B; González M; Gambino D
J Inorg Biochem; 2006 Aug; 100(8):1358-67. PubMed ID: 16698084
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic palladium complexes of bioreductive quinoxaline N1,N4-dioxide prodrugs.
Urquiola C; Vieites M; Torre MH; Cabrera M; Lavaggi ML; Cerecetto H; González M; Cerain AL; Monge A; Smircich P; Garat B; Gambino D
Bioorg Med Chem; 2009 Feb; 17(4):1623-9. PubMed ID: 19162490
[TBL] [Abstract][Full Text] [Related]
3. Novel Cu(II) quinoxaline N1,N4-dioxide complexes as selective hypoxic cytotoxins.
Torre MH; Gambino D; Araujo J; Cerecetto H; González M; Lavaggi ML; Azqueta A; López de Cerain A; Vega AM; Abram U; Costa-Filho AJ
Eur J Med Chem; 2005 May; 40(5):473-80. PubMed ID: 15893021
[TBL] [Abstract][Full Text] [Related]
4. Novel vanadyl complexes with quinoxaline N(1),N(4)-dioxide derivatives as potent in vitro insulin-mimetic compounds.
Noblía P; Vieites M; Torre MH; Costa-Filho AJ; Cerecetto H; González M; Lavaggi ML; Adachi Y; Sakurai H; Gambino D
J Inorg Biochem; 2006 Feb; 100(2):281-7. PubMed ID: 16386797
[TBL] [Abstract][Full Text] [Related]
5. New copper-based complexes with quinoxaline N1,N4-dioxide derivatives, potential antitumoral agents.
Urquiola C; Gambino D; Cabrera M; Lavaggi ML; Cerecetto H; González M; de Cerain AL; Monge A; Costa-Filho AJ; Torre MH
J Inorg Biochem; 2008 Jan; 102(1):119-26. PubMed ID: 17804074
[TBL] [Abstract][Full Text] [Related]
6. Improving anti-trypanosomal activity of 3-aminoquinoxaline-2-carbonitrile N1,N4-dioxide derivatives by complexation with vanadium.
Urquiola C; Vieites M; Aguirre G; Marín A; Solano B; Arrambide G; Noblía P; Lavaggi ML; Torre MH; González M; Monge A; Gambino D; Cerecetto H
Bioorg Med Chem; 2006 Aug; 14(16):5503-9. PubMed ID: 16709457
[TBL] [Abstract][Full Text] [Related]
7. New quinoxaline 1,4-di-N-oxides. Part 1: Hypoxia-selective cytotoxins and anticancer agents derived from quinoxaline 1,4-di-N-oxides.
Amin KM; Ismail MM; Noaman E; Soliman DH; Ammar YA
Bioorg Med Chem; 2006 Oct; 14(20):6917-23. PubMed ID: 16843668
[TBL] [Abstract][Full Text] [Related]
8. Discovery of derivatives of 6(7)-amino-3-phenylquinoxaline-2-carbonitrile 1,4-dioxides: novel, hypoxia-selective HIF-1α inhibitors with strong antiestrogenic potency.
Buravchenko GI; Scherbakov AM; Dezhenkova LG; Bykov EE; Solovieva SE; Korlukov AA; Sorokin DV; Monzote Fidalgo L; Shchekotikhin AE
Bioorg Chem; 2020 Nov; 104():104324. PubMed ID: 33142432
[TBL] [Abstract][Full Text] [Related]
9. Vanadium(V) complexes with salicylaldehyde semicarbazone derivatives bearing in vitro anti-tumor activity toward kidney tumor cells (TK-10): crystal structure of [VVO2(5-bromosalicylaldehyde semicarbazone)].
Noblía P; Vieites M; Parajón-Costa BS; Baran EJ; Cerecetto H; Draper P; González M; Piro OE; Castellano EE; Azqueta A; López de Ceráin A; Monge-Vega A; Gambino D
J Inorg Biochem; 2005 Feb; 99(2):443-51. PubMed ID: 15621276
[TBL] [Abstract][Full Text] [Related]
10. 1, 2, 4-Triazine N-oxide derivatives: studies as potential hypoxic cytotoxins. Part III.
Cerecetto H; González M; Risso M; Saenz P; Olea-Azar C; Bruno AM; Azqueta A; De Ceráin AL; Monge A
Arch Pharm (Weinheim); 2004 May; 337(5):271-80. PubMed ID: 15095420
[TBL] [Abstract][Full Text] [Related]
11. Axial ligand coordination in sterically strained vanadyl porphyrins: synthesis, structure, and properties.
Ghosh SK; Patra R; Rath SP
Inorg Chem; 2008 Nov; 47(21):9848-56. PubMed ID: 18823111
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and characterization of dual function vanadyl, gallium and indium curcumin complexes for medicinal applications.
Mohammadi K; Thompson KH; Patrick BO; Storr T; Martins C; Polishchuk E; Yuen VG; McNeill JH; Orvig C
J Inorg Biochem; 2005 Nov; 99(11):2217-25. PubMed ID: 16171869
[TBL] [Abstract][Full Text] [Related]
13. Design of novel iron compounds as potential therapeutic agents against tuberculosis.
Tarallo MB; Urquiola C; Monge A; Costa BP; Ribeiro RR; Costa-Filho AJ; Mercader RC; Pavan FR; Leite CQ; Torre MH; Gambino D
J Inorg Biochem; 2010 Nov; 104(11):1164-70. PubMed ID: 20701975
[TBL] [Abstract][Full Text] [Related]
14. Bis(dialkyl)dithiocarbamato cobalt(III) complexes of bidentate nitrogen mustards: synthesis, reduction chemistry and biological evaluation as hypoxia-selective cytotoxins.
Ware DC; Palmer HR; Pruijn FB; Anderson RF; Brothers PJ; Denny WA; Wilson WR
Anticancer Drug Des; 1998 Mar; 13(2):81-103. PubMed ID: 9524553
[TBL] [Abstract][Full Text] [Related]
15. Phenazine 5,10-dioxide derivatives as hypoxic selective cytotoxins.
Cerecetto H; González M; Lavaggi ML; Azqueta A; López de Cerain A; Monge A
J Med Chem; 2005 Jan; 48(1):21-3. PubMed ID: 15633996
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-selective antitumor agents. 14. Synthesis and hypoxic cell cytotoxicity of regioisomers of the hypoxia-selective cytotoxin 5-[N,N-bis(2-chloroethyl)amino]-2,4-dinitrobenzamide.
Palmer BD; Wilson WR; Anderson RF; Boyd M; Denny WA
J Med Chem; 1996 Jun; 39(13):2518-28. PubMed ID: 8691449
[TBL] [Abstract][Full Text] [Related]
17. Structural modifications on the phenazine N,N'-dioxide-scaffold looking for new selective hypoxic cytotoxins.
Lavaggi ML; Nieves M; Cabrera M; Olea-Azar C; López de Ceráin A; Monge A; Cerecetto H; González M
Eur J Med Chem; 2010 Nov; 45(11):5362-9. PubMed ID: 20846761
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationships of 1,2,4-benzotriazine 1,4-dioxides as hypoxia-selective analogues of tirapazamine.
Hay MP; Gamage SA; Kovacs MS; Pruijn FB; Anderson RF; Patterson AV; Wilson WR; Brown JM; Denny WA
J Med Chem; 2003 Jan; 46(1):169-82. PubMed ID: 12502371
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia-selective agents derived from quinoxaline 1,4-di-N-oxides.
Monge A; Palop JA; López de Ceráin A; Senador V; Martínez-Crespo FJ; Sainz Y; Narro S; García E; de Miguel C; González M
J Med Chem; 1995 May; 38(10):1786-92. PubMed ID: 7752202
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of 3-aryl-quinoxaline-2-carbonitrile 1,4-di-N-oxide derivatives as hypoxic selective anti-tumor agents.
Hu Y; Xia Q; Shangguan S; Liu X; Hu Y; Sheng R
Molecules; 2012 Aug; 17(8):9683-96. PubMed ID: 22890172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
